Hysterosalpingography for assessing efficacy of essure microinsert permanent birth control device

Michael H. Wittmer, Abimbola O. Famuyide, Douglas J. Creedon, Robert P. Hartman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

OBJECTIVE. The Essure microinsert is a new U.S. Food and Drug Administration-approved method of birth control. The objective of this study is to report our initial experience using hysterosalpingography (HSG) to assess its efficacy for permanent tubal occlusion. CONCLUSION. The Essure microinsert produced tubal blockage in all patients. As this device may become more widely used, radiologists should be aware of the device's appearance and be able to assess device position and presence of tubal occlusion on HSG.

Original languageEnglish (US)
Pages (from-to)955-958
Number of pages4
JournalAmerican Journal of Roentgenology
Volume187
Issue number4
DOIs
StatePublished - Oct 2006

Fingerprint

Hysterosalpingography
Contraception
Tubal Sterilization
Equipment and Supplies
United States Food and Drug Administration

Keywords

  • Birth control
  • Fallopian tube
  • Genitourinary tract imaging
  • Hysterosalpingography
  • Reproductive organ imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Hysterosalpingography for assessing efficacy of essure microinsert permanent birth control device. / Wittmer, Michael H.; Famuyide, Abimbola O.; Creedon, Douglas J.; Hartman, Robert P.

In: American Journal of Roentgenology, Vol. 187, No. 4, 10.2006, p. 955-958.

Research output: Contribution to journalArticle

Wittmer, Michael H. ; Famuyide, Abimbola O. ; Creedon, Douglas J. ; Hartman, Robert P. / Hysterosalpingography for assessing efficacy of essure microinsert permanent birth control device. In: American Journal of Roentgenology. 2006 ; Vol. 187, No. 4. pp. 955-958.
@article{c2ad9d7daf4c4c669c94cad3e4ecd914,
title = "Hysterosalpingography for assessing efficacy of essure microinsert permanent birth control device",
abstract = "OBJECTIVE. The Essure microinsert is a new U.S. Food and Drug Administration-approved method of birth control. The objective of this study is to report our initial experience using hysterosalpingography (HSG) to assess its efficacy for permanent tubal occlusion. CONCLUSION. The Essure microinsert produced tubal blockage in all patients. As this device may become more widely used, radiologists should be aware of the device's appearance and be able to assess device position and presence of tubal occlusion on HSG.",
keywords = "Birth control, Fallopian tube, Genitourinary tract imaging, Hysterosalpingography, Reproductive organ imaging",
author = "Wittmer, {Michael H.} and Famuyide, {Abimbola O.} and Creedon, {Douglas J.} and Hartman, {Robert P.}",
year = "2006",
month = "10",
doi = "10.2214/AJR.05.0525",
language = "English (US)",
volume = "187",
pages = "955--958",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "4",

}

TY - JOUR

T1 - Hysterosalpingography for assessing efficacy of essure microinsert permanent birth control device

AU - Wittmer, Michael H.

AU - Famuyide, Abimbola O.

AU - Creedon, Douglas J.

AU - Hartman, Robert P.

PY - 2006/10

Y1 - 2006/10

N2 - OBJECTIVE. The Essure microinsert is a new U.S. Food and Drug Administration-approved method of birth control. The objective of this study is to report our initial experience using hysterosalpingography (HSG) to assess its efficacy for permanent tubal occlusion. CONCLUSION. The Essure microinsert produced tubal blockage in all patients. As this device may become more widely used, radiologists should be aware of the device's appearance and be able to assess device position and presence of tubal occlusion on HSG.

AB - OBJECTIVE. The Essure microinsert is a new U.S. Food and Drug Administration-approved method of birth control. The objective of this study is to report our initial experience using hysterosalpingography (HSG) to assess its efficacy for permanent tubal occlusion. CONCLUSION. The Essure microinsert produced tubal blockage in all patients. As this device may become more widely used, radiologists should be aware of the device's appearance and be able to assess device position and presence of tubal occlusion on HSG.

KW - Birth control

KW - Fallopian tube

KW - Genitourinary tract imaging

KW - Hysterosalpingography

KW - Reproductive organ imaging

UR - http://www.scopus.com/inward/record.url?scp=33748987607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748987607&partnerID=8YFLogxK

U2 - 10.2214/AJR.05.0525

DO - 10.2214/AJR.05.0525

M3 - Article

VL - 187

SP - 955

EP - 958

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 4

ER -